Citation Impact
Citing Papers
Diabetes and Kidney Disease: Role of Oxidative Stress
2016
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction
2001
Pharmacological properties of Salvia officinalis and its components
2017 Standout
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
Q10 therapy in patients with idiopathic Parkinson's disease
1997
Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes
2012
Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy
1998
Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo31P-MRS in a patient with mitochondrial cytopathy
1995
Magnetic Resonance Spectroscopy in Traumatic Brain Injury
2001
TGF-β: the master regulator of fibrosis
2016 Standout
Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?
2013
Coenzyme Q10 as a therapy for mitochondrial disease
2014
Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
2014
Mitochondrial Encephalopathy, Lactic Acidosis, and Strokelike Episodes
2008
Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research
1998
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity
1995
Metabolic Regulation by p53 Family Members
2013
Coenzyme Q10 suppresses oxLDL‐induced endothelial oxidative injuries by the modulation of LOX‐1‐mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway
2011
Effects of Coenzyme Q10 in Early Parkinson Disease
2002
Insulin and insulin resistance:
2004 Standout
The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age‐Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults
2016 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems
2012
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
p47phox contributes to albuminuria and kidney fibrosis in mice
2015
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease
2007
Mitochondria and cancer
2012 Standout
ROS signalling in the biology of cancer
2017 Standout
Lipid‐lowering drugs and mitochondrial function: effects of HMG‐CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio
1996
Cellular senescence: from physiology to pathology
2014 Standout
Decrease and Recovery of N -Acetylaspartate/Creatine in Rat Brain Remote from Focal Injury
2001
The Role of Oxidative Stress in Neurodegenerative Diseases
2015 Standout
Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
2014
Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes
2013
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine
2000 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Effect of high‐dose vitamins, coenzyme Q and high‐fat diet in paediatric patients with mitochondrial diseases
2004
The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo
2013
Physicochemical Foundations of Life that Direct Evolution: Chance and Natural Selection are not Evolutionary Driving Forces
2020
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
2013 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Nox as a target for diabetic complications
2013
Mitochondrial Energetics and Therapeutics
2010
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Bridget Ford being referenced
Presence of a consensus DNA motif at nearby DNA sequence of the mutation susceptible CG nucleotides
2017
AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in Diabetes
2010
Mammalian Target of Rapamycin Regulates Nox4-Mediated Podocyte Depletion in Diabetic Renal Injury
2013
Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
1995
ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice
2013
Coenzyme Q 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease
1993